Published in Carcinogenesis on April 01, 1998
Topical Green Tea Ointment in Treatment of Superficial Skin Cancer | NCT02029352
Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer (2009) 3.90
Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci U S A (2001) 2.79
Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proc Natl Acad Sci U S A (2002) 1.99
Laboratory and clinical studies of cancer chemoprevention by antioxidants in berries. Carcinogenesis (2008) 1.47
Pro-oxidative activities and dose-response relationship of (-)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro. Carcinogenesis (2010) 1.24
Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications. Blood (2006) 1.21
Micronutrient synergy--a new tool in effective control of metastasis and other key mechanisms of cancer. Cancer Metastasis Rev (2010) 1.16
Expanding circle of inhibition: small-molecule inhibitors of Bcl-2 as anticancer cell and antiangiogenic agents. J Clin Oncol (2008) 1.13
Apple polyphenol extracts prevent damage to human gastric epithelial cells in vitro and to rat gastric mucosa in vivo. Gut (2005) 1.11
EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment. Adv Clin Chem (2011) 1.05
(-)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cells. Carcinogenesis (2008) 1.04
Oxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy. J Cell Mol Med (2009) 1.03
Biomedical potential of silver nanoparticles synthesized from calli cells of Citrullus colocynthis (L.) Schrad. J Nanobiotechnology (2011) 1.01
Recent advances on tea polyphenols. Front Biosci (Elite Ed) (2012) 1.00
Autoxidative quinone formation in vitro and metabolite formation in vivo from tea polyphenol (-)-epigallocatechin-3-gallate: studied by real-time mass spectrometry combined with tandem mass ion mapping. Free Radic Biol Med (2007) 0.99
Modulation of N-methyl-N-nitrosourea induced mammary tumors in Sprague-Dawley rats by combination of lysine, proline, arginine, ascorbic acid and green tea extract. Breast Cancer Res (2005) 0.97
Overview of major classes of plant-derived anticancer drugs. Int J Biomed Sci (2009) 0.96
Research strategies in the study of the pro-oxidant nature of polyphenol nutraceuticals. J Toxicol (2011) 0.94
Green tea extract selectively targets nanomechanics of live metastatic cancer cells. Nanotechnology (2011) 0.93
Targeted deletion of Rad9 in mouse skin keratinocytes enhances genotoxin-induced tumor development. Cancer Res (2008) 0.91
Antioxidant induces DNA damage, cell death and mutagenicity in human lung and skin normal cells. Sci Rep (2013) 0.91
Green tea consumption and lung cancer risk: the Ohsaki study. Br J Cancer (2008) 0.91
In vitro modulation of MMP-2 and MMP-9 in adult human sarcoma cell lines by cytokines, inducers and inhibitors. Int J Oncol (2013) 0.88
Cancer Therapy by Catechins Involves Redox Cycling of Copper Ions and Generation of Reactive Oxygenspecies. Toxins (Basel) (2016) 0.87
Green tea polyphenols induce p53-dependent and p53-independent apoptosis in prostate cancer cells through two distinct mechanisms. PLoS One (2012) 0.86
Epigallocatechin-3-gallate suppresses proinflammatory cytokines and chemokines induced by Toll-like receptor 9 agonists in prostate cancer cells. J Inflamm Res (2014) 0.86
Reduction of oxidative stress in liver cancer patients by oral green tea polyphenol tablets during hepatic arterial infusion chemotherapy. Exp Ther Med (2012) 0.86
In vitro modulation of MMP-2 and MMP-9 in pediatric human sarcoma cell lines by cytokines, inducers and inhibitors. Int J Oncol (2013) 0.86
Green tea compound in chemoprevention of cervical cancer. Int J Gynecol Cancer (2010) 0.86
Complementary and alternative medicines in prostate cancer: from bench to bedside? Oncologist (2012) 0.85
Green tea polyphenols potentiate the action of nerve growth factor to induce neuritogenesis: possible role of reactive oxygen species. J Neurosci Res (2010) 0.84
Green tea polyphenols function as prooxidants to activate oxidative-stress-responsive transcription factors in yeasts. Appl Environ Microbiol (2006) 0.83
Challenging the effectiveness of green tea in primary and tertiary cancer prevention. J Cancer Res Clin Oncol (2012) 0.82
Green tea and the risk of gastric cancer: epidemiological evidence. World J Gastroenterol (2013) 0.81
Toxicological aspects of the use of phenolic compounds in disease prevention. Interdiscip Toxicol (2011) 0.81
Synergistic effects of tea polyphenols and ascorbic acid on human lung adenocarcinoma SPC-A-1 cells. J Zhejiang Univ Sci B (2010) 0.81
Immunomodulators in warts: Unexplored or ineffective? Indian J Dermatol (2015) 0.80
Anticancer effect of black tea extract in human cancer cell lines. Springerplus (2015) 0.80
(-)-Epigallocatechin-3-gallate protects mice from concanavalin A-induced hepatitis through suppressing immune-mediated liver injury. Clin Exp Immunol (2006) 0.80
Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human lung cancer and mesothelioma cell lines. Int J Oncol (2013) 0.80
The antioxidants dilemma: are they potentially immunosuppressants and carcinogens? Front Physiol (2014) 0.80
Induction of Apoptosis and Cytotoxic Activities of Iranian Orthodox Black Tea Extract (BTE) Using in vitro Models. Adv Pharm Bull (2014) 0.80
Binding of natural and synthetic polyphenols to human dihydrofolate reductase. Int J Mol Sci (2009) 0.80
Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human female cancer cell lines. Oncol Rep (2012) 0.80
Anticancer Efficacy of Polyphenols and Their Combinations. Nutrients (2016) 0.80
Safety and chemopreventive effect of Polyphenon E in preventing early and metastatic progression of prostate cancer in TRAMP mice. Cancer Prev Res (Phila) (2014) 0.79
Urinary biomarkers of catechins and risk of hepatocellular carcinoma in the Shanghai Cohort Study. Am J Epidemiol (2015) 0.79
Effects of a nutrient mixture on immunohistochemical localization of cancer markers in human cervical cancer HeLa cell tumor xenografts in female nude mice. Exp Ther Med (2014) 0.79
Black tea polyphenols inhibit tumor proteasome activity. In Vivo (2012) 0.79
In vitro and in vivo inhibition of human Fanconi anemia-associated head and neck squamous cell carcinoma by a novel nutrient mixture. Int J Oncol (2012) 0.78
Metabogenic and Nutriceutical Approaches to Address Energy Dysregulation and Skeletal Muscle Wasting in Duchenne Muscular Dystrophy. Nutrients (2015) 0.77
Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in pediatric human sarcoma cell lines. Int J Oncol (2013) 0.77
Protective effect of black tea infusion on aflatoxin-induced hepatotoxicity in mice. J Clin Exp Hepatol (2012) 0.77
Inhibition of catalase by tea catechins in free and cellular state: a biophysical approach. PLoS One (2014) 0.77
Phytochemicals modulate carcinogenic signaling pathways in breast and hormone-related cancers. Onco Targets Ther (2015) 0.77
Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in adult human sarcoma cell lines. Int J Oncol (2013) 0.77
Effect of a nutrient mixture on the localization of extracellular matrix proteins in HeLa human cervical cancer xenografts in female nude mice. Exp Ther Med (2015) 0.77
Inhibition of the SK-N-MC human neuroblastoma cell line in vivo and in vitro by a novel nutrient mixture. Oncol Rep (2013) 0.76
Activity of green tea polyphenol epigallocatechin-3-gallate against ovarian carcinoma cell lines. Cancer Res Treat (2004) 0.76
A Specific Mixture of Nutrients Suppresses Ovarian Cancer A-2780 Tumor Incidence, Growth, and Metastasis to Lungs. Nutrients (2017) 0.75
The hepatoprotective activity of olive oil and Nigella sativa oil against CCl4 induced hepatotoxicity in male rats. BMC Complement Altern Med (2016) 0.75
Pre- and post-initiation modulating effects of green tea ingestion on rat hepatocarcinogenesis. Nutr Res Pract (2008) 0.75
Effects of (-)-epigallocatechin gallate (EGCG) on DNA strand breaks as evaluated by single-cell gel electrophoresis (SCG) in human lymphocytes. Environ Health Prev Med (2001) 0.75
Quality, antioxidant activity and composition of Indian black teas. J Food Sci Technol (2017) 0.75
Flavan-3-ols consumption and cancer risk: A meta-analysis of epidemiologic studies. Oncotarget (2016) 0.75
Micronutrient Synergy in the Fight against Hepatocellular Carcinoma. Cancers (Basel) (2012) 0.75
Suppression of metastasis of intratesticular inoculation of B16FO melanoma cells by a novel nutrient mixture in male athymic nude mice. Exp Ther Med (2012) 0.75
N-Acetylcysteine enhances the lung cancer inhibitory effect of epigallocatechin-3-gallate and forms a new adduct. Free Radic Biol Med (2007) 0.75
Chemopreventive and Anticancer Activities of Allium victorialis var. platyphyllum Extracts. J Cancer Prev (2014) 0.75
Tea polyphenols prevent lung from preneoplastic lesions and effect p53 and bcl-2 gene expression in rat lung tissues. Int J Clin Exp Pathol (2013) 0.75
Cytotoxic Activity and Chemical Composition of the Root Extract from the Mexican Species Linum scabrellum: Mechanism of Action of the Active Compound 6-Methoxypodophyllotoxin. Evid Based Complement Alternat Med (2015) 0.75
Mechanism of EGCG promoting apoptosis of MCF-7 cell line in human breast cancer. Oncol Lett (2017) 0.75
Camellia sinensis increased apoptosis on U2OS osteosarcoma cells and wound healing potential on NIH3T3 fibroblast cells. Cytotechnology (2017) 0.75
Emerging marine diseases--climate links and anthropogenic factors. Science (1999) 10.22
A roadmap for graphene. Nature (2012) 8.66
Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst (1993) 8.30
Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med (1999) 5.84
PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol Microbiol (1998) 5.01
Specific inhibition of Stat3 signal transduction by PIAS3. Science (1997) 4.74
Excision of deoxyribose phosphate residues by DNA polymerase beta during DNA repair. Science (1995) 4.22
Inhibition of Stat1-mediated gene activation by PIAS1. Proc Natl Acad Sci U S A (1998) 4.12
Rapid diagnosis of pulmonary tuberculosis by using Roche AMPLICOR Mycobacterium tuberculosis PCR test. J Clin Microbiol (1995) 4.11
Retinylidene proteins: structures and functions from archaea to humans. Annu Rev Cell Dev Biol (2000) 4.01
CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol (2001) 3.44
Complementary DNA and protein sequences of ethanol-inducible rat and human cytochrome P-450s. Transcriptional and post-transcriptional regulation of the rat enzyme. J Biol Chem (1986) 3.39
Research on esophageal cancer in China: a review. Cancer Res (1980) 3.17
Peroxiredoxin, a novel family of peroxidases. IUBMB Life (2001) 2.91
Molecular basis for interactions of G protein betagamma subunits with effectors. Science (1998) 2.88
Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha. J Biol Chem (1998) 2.66
Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel. Proc Natl Acad Sci U S A (2001) 2.62
Papillary cystic and solid tumors of the pancreas: a pancreatic embryonic tumor? Studies of three cases and cumulative review of the world's literature. Surgery (1995) 2.50
Analysis of repeated categorical data using generalized estimating equations. Stat Med (1994) 2.44
Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome. EMBO Rep (2001) 2.43
Proliferating cell nuclear antigen-dependent abasic site repair in Xenopus laevis oocytes: an alternative pathway of base excision DNA repair. Mol Cell Biol (1994) 2.42
In vitro inhibition of diphtheria toxin action by ammonium salts and amines. J Bacteriol (1965) 2.38
Wavelet filter evaluation for image compression. IEEE Trans Image Process (1995) 2.27
Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med (2001) 2.26
Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase. Mol Cell Biol (2000) 2.24
Psychometric assessment of subjective sleep quality using the Japanese version of the Pittsburgh Sleep Quality Index (PSQI-J) in psychiatric disordered and control subjects. Psychiatry Res (2000) 2.15
Regulation of GLUT1 gene transcription by the serine/threonine kinase Akt1. J Biol Chem (1999) 2.13
Supplementation with vitamins C and E enhances cytokine production by peripheral blood mononuclear cells in healthy adults. Am J Clin Nutr (1996) 2.08
Cloning, sequencing, and mutation of thiol-specific antioxidant gene of Saccharomyces cerevisiae. J Biol Chem (1993) 2.04
Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J Biol Chem (2000) 2.04
Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients. J Am Coll Cardiol (1991) 2.03
Potential antifolate resistance determinants and genotypic variation in the bifunctional dihydrofolate reductase-thymidylate synthase gene from human and bovine isolates of Cryptosporidium parvum. Mol Biochem Parasitol (1996) 2.02
Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH. Proc Natl Acad Sci U S A (1999) 2.02
IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J Immunol (1999) 2.00
Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions. J Control Release (2001) 1.94
Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst (1993) 1.91
A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control. Proc Natl Acad Sci U S A (2001) 1.88
Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol Biomarkers Prev (2001) 1.87
The development and biology of bradyzoites of Toxoplasma gondii. Front Biosci (2000) 1.84
Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carcinogenesis. Cancer Res (1993) 1.81
Phosphorylation of human keratin 18 serine 33 regulates binding to 14-3-3 proteins. EMBO J (1998) 1.80
The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy. Clin Genet (2004) 1.79
Mode of inhibition of diphtheria toxin by ammonium chloride. J Bacteriol (1965) 1.79
Enhancement of antiproliferative activity of gamma interferon by the specific inhibition of tyrosine dephosphorylation of Stat1. Mol Cell Biol (1996) 1.79
Nonenzymatic cleavage of proteins by reactive oxygen species generated by dithiothreitol and iron. J Biol Chem (1985) 1.78
The final stages of spliceosome maturation require Spp2p that can interact with the DEAH box protein Prp2p and promote step 1 of splicing. RNA (1995) 1.77
Principles for designing randomized preventive trials in mental health: an emerging developmental epidemiology paradigm. Am J Community Psychol (1999) 1.76
Postoperative chemoradiotherapy for gastric cancer. Ann Oncol (2003) 1.73
Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology (1990) 1.72
Apoptosis generates stable fragments of human type I keratins. J Biol Chem (1997) 1.72
Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol Biomarkers Prev (1995) 1.70
Absorption, distribution, elimination of tea polyphenols in rats. Drug Metab Dispos (1997) 1.69
Human ethanol-inducible P450IIE1: complete gene sequence, promoter characterization, chromosome mapping, and cDNA-directed expression. Biochemistry (1988) 1.69
Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymers. J Control Release (2003) 1.69
Hepatitis B virus markers in Chinese twins. Anticancer Res (1989) 1.68
Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem Res Toxicol (1993) 1.67
p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res (1994) 1.66
Keratin modifications and solubility properties in epithelial cells and in vitro. Subcell Biochem (1998) 1.66
Genetic analysis of the VP1 region of human enterovirus 71 strains isolated in Korea during 2000. Arch Virol (2003) 1.64
Expression of zebrafish bHLH genes ngn1 and nrd defines distinct stages of neural differentiation. Dev Dyn (1998) 1.63
Outbreaks of diarrhea associated with Clostridium difficile and its toxin in day-care centers: evidence of person-to-person spread. J Pediatr (1983) 1.63
Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis. Int J Cancer (1994) 1.63
Proliferating cell nuclear antigen facilitates excision in long-patch base excision repair. J Biol Chem (1999) 1.60
Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center. Vaccine (2005) 1.59
Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results. J Natl Cancer Inst (1993) 1.59
Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis. Ophthalmology (1998) 1.58
Binding properties of immunoglobulin combining sites specific for terminal or nonterminal antigenic determinants in dextran. J Exp Med (1975) 1.57
Anxiety disorders during acute bereavement: risk and risk factors. J Clin Psychiatry (1990) 1.57
Epstein-Barr virus transcription in nasopharyngeal carcinoma. J Virol (1983) 1.57
Magnetic resonance microscopy of the C57BL mouse brain. Neuroimage (2000) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Surgical curability and prognosis for standard versus extended resection for T1 carcinoma of the pancreas. Surg Gynecol Obstet (1992) 1.55
Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst (2000) 1.55
Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis (1997) 1.53
Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol (1994) 1.51
Congestion of right liver graft in living donor liver transplantation. Transplantation (2001) 1.51
Primary human herpesvirus 6 infections in children: a prospective serologic study. J Infect Dis (1992) 1.50
Atomic force microscopy of long and short double-stranded, single-stranded and triple-stranded nucleic acids. Nucleic Acids Res (1996) 1.50
DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas. Carcinogenesis (2001) 1.50
The vitamin D-responsive element in the human osteocalcin gene. Association with a nuclear proto-oncogene enhancer. J Biol Chem (1990) 1.49
LIVER EXTRACT, LIVER ASH AND IRON IN THE TREATMENT OF ANEMIA. J Clin Invest (1930) 1.47
3-D correlation-based speckle tracking. Ultrason Imaging (2005) 1.46
Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis (2001) 1.45
Observations on the developmental patterns and the consequences of pancreatic exocrine adenocarcinoma. Findings of 154 autopsies. Arch Surg (1995) 1.44
FMRFamide-related neuropeptide gene family in Caenorhabditis elegans. Brain Res (1999) 1.44
One micrometer resolution NMR microscopy. J Magn Reson (2001) 1.44
Determination of benflumetol in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Appl (1996) 1.44
CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst (1997) 1.43
Tight clustering of human hepatitis B virus integration sites in hepatomas near a triple-stranded region. J Virol (1987) 1.42
Prospective analysis of outcome after cardiopulmonary resuscitation in critically ill surgical patients. J Am Coll Surg (1995) 1.42
Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2. J Biol Chem (1998) 1.42
Re: Long-term survival and mortality in prostate cancer treated with noncurative intent. J Urol (1996) 1.41
Short- and long-term clinical effects of primary directional coronary atherectomy for acute myocardial infarction. Cathet Cardiovasc Diagn (1996) 1.40
Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. J Pharmacol Exp Ther (1990) 1.38
Removals of hydrogen peroxide and hydroxyl radical by thiol-specific antioxidant protein as a possible role in vivo. Biochem Biophys Res Commun (1993) 1.38
Melanoma differentiation associated gene-7 (mda-7): a novel anti-tumor gene for cancer gene therapy. Mol Med (2001) 1.37